[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 22, Pages 4090
Publisher
MDPI AG
Online
2019-11-13
DOI
10.3390/molecules24224090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice
- (2019) Benoît Souchet et al. Acta Neuropathologica Communications
- Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design
- (2018) Rosanna Meine et al. MOLECULES
- DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
- (2018) Fernanda Neumann et al. Scientific Reports
- Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
- (2018) Thu Lan Nguyen et al. Disease Models & Mechanisms
- Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature
- (2017) Thu Lan Nguyen et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases
- (2017) Nadège Loaëc et al. Marine Drugs
- MolProbity: More and better reference data for improved all-atom structure validation
- (2017) Christopher J. Williams et al. PROTEIN SCIENCE
- Tools for ligand validation inCoot
- (2017) Paul Emsley Acta Crystallographica Section D-Structural Biology
- Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure
- (2016) Yannick J. Esvan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- DYRK1A inhibition as potential treatment for Alzheimer’s disease
- (2016) Silvia Stotani et al. Future Medicinal Chemistry
- An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases
- (2016) Apirat Chaikuad et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective inhibition of the kinase DYRK1A by targeting its folding process
- (2016) Isao Kii et al. Nature Communications
- DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
- (2016) Arnaud Duchon et al. Frontiers in Behavioral Neuroscience
- 10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A
- (2015) Hannes Falke et al. JOURNAL OF MEDICINAL CHEMISTRY
- DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications
- (2015) Ramzi Abbassi et al. PHARMACOLOGY & THERAPEUTICS
- DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
- (2014) Walter Becker et al. CNS & Neurological Disorders-Drug Targets
- Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II
- (2014) Alicia Foucourt et al. MOLECULES
- DYRK1A-mediated phosphorylation of GluN2A at Ser1048 regulates the surface expression and channel activity of GluN1/GluN2A receptors
- (2014) Cristina Grau et al. Frontiers in Cellular Neuroscience
- Decision making inxia2
- (2013) Graeme Winter et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines
- (2013) Guillaume Burgy et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
- (2013) Natividad Pozo et al. JOURNAL OF CLINICAL INVESTIGATION
- The Protein Interaction Landscape of the Human CMGC Kinase Group
- (2013) Markku Varjosalo et al. Cell Reports
- Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?
- (2012) Breland Smith et al. ACS Chemical Neuroscience
- Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control
- (2012) Walter Becker CELL CYCLE
- Optimizing solubility: Kinetic versus thermodynamic solubility temptations and risks
- (2012) Christoph Saal et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B
- (2012) Tania Tahtouh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
- (2012) Rainer Wilcken et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fischer Indole Synthesis in Low Melting Mixtures
- (2012) Sangram Gore et al. ORGANIC LETTERS
- An introduction to data reduction: space-group determination, scaling and intensity statistics
- (2011) Philip R. Evans ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
- (2011) Oleg Fedorov et al. CHEMISTRY & BIOLOGY
- Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling
- (2011) B. Hammerle et al. DEVELOPMENT
- Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative Pre-RNA Splicing
- (2011) Mansour Debdab et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of DYRK1A in neurodegenerative diseases
- (2010) Jerzy Wegiel et al. FEBS Journal
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development
- (2008) Ariadna Laguna et al. DEVELOPMENTAL CELL
- DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine
- (2008) Anne Seifert et al. FEBS Journal
- Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome
- (2008) Jianhua Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now